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Abstract
Background: After alcohol and tobacco, cannabis is the most widely used psychoactive substance in many countries worldwide.
Although approximately one in ten users develops serious problems of dependency, only a minority attend outpatient addiction
counseling centers. A Web-based intervention could potentially reach those users who hesitate to approach such treatment centers.
Objective: To test the efficacy of a Web-based self-help intervention with and without chat counseling—Can Reduce—in
reducing the cannabis use of problematic cannabis users as an alternative to outpatient treatment services.
Methods: Altogether, 436 participants were recruited by various online and offline media for the Web-based trial. A total of
308 of these were eligible for study participation and were randomly allocated in an unblinded manner to either self-help with
chat (n=114), self-help without chat (n=101), or a waiting list control group (n=93). The fully automated self-help intervention
consisted of eight modules designed to reduce cannabis use, and was based on the principles of motivational interviewing,
self-control practices, and methods of cognitive behavioral therapy. Additional individual chat counseling sessions were based
on the same therapeutic principles. The sessions were conducted by trained counselors and addressed participants' personal
problems. The main outcomes were the frequency (number of days) and quantity of cannabis use (number of standardized joints)
per week, as entered into the consumption diary at baseline and at the 3-month follow-up. Secondary outcomes included self-reported
symptoms of cannabis use disorder, severity of cannabis dependence, risky alcohol use, and mental health symptoms. Intervention
participation and retention were extracted from the user progress data and the consumption diary, respectively.
Results: Can Reduce participants were older (U=2.296, P=.02) and reported a greater number of cannabis use days at baseline
than patients who entered outpatient treatment with cannabis as their main problem substance (data from the Swiss treatment
demand monitoring statistics were used; chi-square [df 2]=4.0, P=.046). Participants in the self-help with chat study arm completed
a mean of 3.2 modules and 27 out of 114 (23.7%) of the participants received at least one chat session. Participants in the self-help
without chat study arm completed similar numbers of self-help modules. A total of 117 of 308 participants (38.0%) completed
the 3-month follow-up assessment. The change in the mean number of cannabis use days per week at 3 months differed between
self-help without chat (mean change 0.7, SD -0.2) and self-help with chat (mean change 1.4, SD -0.5; beta=-0.75, SE=0.32,
t=-2.39, P=.02, d=0.34, 95% CI 0.07-0.61), as well as between self-help with chat and waiting list (mean change 1.0, SD -0.8;
beta=0.70, SE=0.32, t=2.16, P=.03, d=0.20, 95% CI -0.07 to 0.47). However, there were no differences between self-help without
chat and waiting list (beta=-0.05, SE=0.33, t=-0.16, P=.87, d=-0.14, 95% CI -0.43 to 0.14). Self-reported abstinence was significantly
different in the self-help without chat study arm (2.0%) than in the self-help with chat study arm (8.8%; beta=-1.56, SE=0.79,
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P=.05, odds ratio [OR]=0.21, 95% CI 0.02-2.33). There were no significant differences between the study arms with respect to
the secondary outcomes.
Conclusions: Web-based self-help interventions supplemented by brief chat counseling are an effective alternative to face-to-face
treatment and can reach a group of cannabis users who differ in their use and sociodemographic characteristics from those who
enter outpatient addiction treatment.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 59948178;
http://www.isrctn.com/ISRCTN59948178 (Archived by WebCite at http://www.webcitation.org/6bt01gfIr)
(J Med Internet Res 2015;17(10):e232)   doi:10.2196/jmir.4860
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behavioral self-management
Introduction
Web-based self-help programs that aim to reduce cannabis use
might help to reach cannabis users who do not want to enter
available outpatient addiction counseling services due to their
fear of being stigmatized or their need to distance themselves
socially from drug counselors [1]. Moreover, the limited opening
hours of many outpatient addiction services might act as a barrier
to care for some users [1]. It has been estimated that
approximately 22% of Europeans between 15 and 64 years of
age have tried cannabis. A total of 6.8% of Europeans report
using cannabis in the preceding month and an estimated 3
million report daily cannabis use [2]. Switzerland has the
third-highest national prevalence of cannabis use in Europe; the
12-month prevalence rate is 5.7% (men 7.8%, women 3.7%)
and the 30-day prevalence rate is 2.7% (men 3.7%, women
1.7%) [3]. The age group with the highest prevalence is between
15 and 24 years of age; this group has a 12-month prevalence
rate of 19.9%, and nearly one in five members from this group
uses cannabis daily [3]. Daily cannabis use is associated with
greater risks of developing cannabis dependence, poor mental
and physical health, lower educational achievement, and
decreased cognitive functioning [4]. The risks of cannabis
dependence [5] and problems with cannabis use [6] are
considerably higher in cannabis users with early rather than late
onset of use.
Treatment demand statistics from Swiss in- and outpatient
addiction treatment centers demonstrated a linear increase—from
2006 (9.9%) to 2012 (14.7%)—in new treatment entry cases
for whom cannabis was the main problem substance [7]. The
main group seeking treatment for cannabis use disorder mainly
consists of adolescents and young adults between the ages of
15 and 24 years old (71.6%) and are predominantly male
(82.5%) [8]. In Europe, cannabis is the main problem substance
for almost 40% of all individuals entering addiction treatment
for the first time and has been a more frequent problem than
opioids since 2006 [9]. It has been estimated that about 50% of
problematic cannabis users will develop cannabis dependence
[5] and many of these exhibit mental health problems; however,
most of them are not yet in treatment. Raising awareness of
cannabis-related risks to physical health might also encourage
users to reduce or quit cannabis use [10]. In general, the
principle of stepped care (ie, noninvasive, low-cost interventions
in which therapeutic intensity can be enhanced according to
need) appears to be an appropriate means for problematic
cannabis users to lower their ever-increasing health care costs
[11], and this consideration is of interest in Switzerland and
other industrialized countries suffering from exorbitant health
costs.
An initial meta-analysis included diverse studies that mainly
investigated computer- and some Web-based interventions to
reduce cannabis consumption and found a small overall effect
size (g=0.16, 95% CI 0.09-0.22, P<.001) at posttreatment. There
have now been three studies on the efficacy of Web-based
interventions to reduce cannabis use in problematic users. First,
the German Quit the Shit program [12] is based on principles
of self-regulation and self-control and is a solution-focused
approach. This program is structured into weekly personalized
feedback sessions based on participants’ consumption diary
entries, and intake and termination chats; the total allowed
program time is 50 days. Tossmann et al [12] recruited a total
of 1292 cannabis users and found significant reductions in
cannabis use in their intention-to-treat (ITT) analyses, but with
high attrition rates. Second, a distinct version of the program
was developed that consisted of one comprehensive chat session
with motivational interviewing (MI) [13] in the intervention
group (n=33) versus a technical information chat in the control
group (n=34). No significant differences in cannabis use were
found between the study groups [14]. Third, the Australian
program, Reduce Your Use: How to Break the Cannabis Habit
[15], is a fully automated self-help intervention consisting of
six modules that aim to reduce the symptoms of cannabis use
disorders and which is based on cognitive behavioral therapy
(CBT) [16,17], MI [13], and behavioral self-management (BSM)
[18]. Its efficacy was tested in a randomized controlled trial
(RCT) and compared to a psychoeducative control condition
that also consisted of six modules (n=225). The frequency of
cannabis use and the quantity of cannabis consumed were both
reduced to a greater extent in the intervention group than in the
control group at 6 weeks and at the 3-month follow-up. They
achieved considerably higher participation rates at the 3-month
follow-up than the German Quit the Shit program (54% in the
intervention and 52% in the control condition) [12].
The combination of a fully automated self-help intervention
based on the approaches of Rooke et al [15], together with
additional individual chat sessions to reduce cannabis use, could
potentially increase the efficacy of interventions for problematic
cannabis users—in the sense that the use is harmful to the user
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or others—as has been demonstrated for the reduction of alcohol
use in problematic alcohol users [19].
Thus, the current study aims to investigate and compare the
efficacy of Web-based self-help interventions—in combination
with or without tailored chat counseling based on CBT, MI, and
BSM—in reducing cannabis use in problematic cannabis users.
Methods
Participants
Study participants were recruited by a press release, several
websites from local outpatient treatment centers, and from
nightlife prevention websites that were linked to the Can Reduce
website [20]. In addition, advertisements were placed in Internet
forums and recruitment flyers were distributed to Swiss
addiction service centers and practitioners in the Canton of
Zurich. Moreover, two major Swiss commuter newspapers and
one Swiss weekend newspaper published extensive reports on
the Can Reduce interventions in their print media and websites.
The collaboration of the Swiss Research Institute for Public
Health and Addiction (ISGF) and the Arud Centers for Addiction
Medicine (ARUD) as the responsible study institutions was
clearly stated in all recruitment channels.
Study inclusion and exclusion criteria are depicted in Table 1.
In addition to the email addresses in the registration process,
participants were asked to provide their telephone numbers in
case they could not be reached online for the 3-month follow-up
[1]. The participant information and informed consent page
from the Can Reduce website is provided in Multimedia
Appendix 1.
Table 1. Inclusion and exclusion criteria and rationales.
RationalesParticipant criteria
Inclusion criteria
To ensure a minimal age of participationMinimum age of 18 years
To ensure understanding of interventionsRead and understand German
To ensure participationInternet access and a valid email address
To include at least occasional usersUsing cannabis at least once a week over the 30 days prior to study entry
Exclusion criteria
To avoid exacerbation of serious symptoms of these severe
psychiatric disorders
Current serious psychiatric disorders or history of psychosis, schizophrenia, bipolar
type I disorder, or significant current suicidal or homicidal thoughts
To avoid confounding treatment effectsOther pharmacological or psychosocial treatments for cannabis use disorders
To avoid serious complications resulting, for example, from
withdrawal symptoms
For women: pregnancy and breastfeeding
Preparatory Work
The Web-based self-help intervention, Can Reduce, was based
on classical CBT approaches for treating cannabis dependence
[17], MI approaches [13], and BSM [18]. A detailed description
of the intervention can be found in the study protocol by Schaub
et al [1]. This randomized controlled trial was registered with
the International Standard Randomized Controlled Trial Number
(ISRCTN) registry (ISRCTN59948178).
Can Reduce is the first self-help intervention for problematic
cannabis users in Switzerland. It was developed by the authors
of this publication from the ISGF and the ARUD. Both
institutions are located in the Canton of Zurich, Switzerland.
Study participation was free of charge. The self-help part of
Can Reduce was developed according to the experiences of an
earlier study in problematic cocaine users [21,22] and the Global
Drug Survey cannabis meter [23], and was piloted for
acceptability and usability. The piloting was organized into two
steps. In the first step, we piloted Can Reduce with
cannabis-using students from the University of Zurich. In the
second step, we combined this with additional chat sessions
with two trained psychiatrists from ARUD and four of their
problematic cannabis-using patients. This pilot phase resulted
in some minor changes in the interventions.
Ethical Review and Informed Consent
The protocol of the RCT was approved by the Ethics Committee
of the Canton of Zurich (KEK-StV-Nr. 15/13) and was carried
out in compliance with the Helsinki Declaration. Before giving
informed consent, participants were informed of the following:
(1) the rationale of the study, (2) study inclusion and exclusion
criteria (see Table 1), (3) the three different arms and their 1:3
chance of being allocated to one of the arms, (4) the potential
risks of participation, (5) safety arrangements during and after
the study phase [19], (6) the inability of Can Reduce (with or
without chat counseling) to replace face-to-face therapy for
problematic cannabis use/abuse, (7) the circumstances under
which they should contact their general practitioner or a
professional from a medical advisory group; an emergency list
that would be accessible at all times via an instant help button
was provided as well, (8) the approval of the study by the Ethics
Committee of the Canton of Zurich and their declaration of no
objection (nihil obstat), and (9) their right to withdraw from the
study at any time without consequences except for the loss of
further compensation. Informed consent was accepted when
participants clicked on all consent fields of the informed consent
page and submitted the consent by clicking the submission
button (see Multimedia Appendix 1).
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Study Arms and Contents
There were three different study arms. The first consisted of the
Web-based self-help intervention, Can Reduce, in combination
with up to two individual chat counseling sessions based on MI
and CBT approaches that considered the data the participants
entered into the self-help intervention and individual requests.
The second study arm consisted of the same intervention but
without chat counseling. Study arms 1 and 2 received weekly
automated motivational emails to remind the user to log in and
fill out the consumption diary. Study arm 3 consisted of a
classical waiting list and people in this arm received access to
the self-help intervention after 3 months.
The following modules, organized into three main parts, were
offered as a Web-based self-help intervention (study arms 1 and
2) and—as long as the participant did not feel an urgent need
to skip to a specific module—it was recommended that they
should be worked through in the order shown in Textbox 1
within the planned 6 weeks of intervention.
Textbox 1. Modules for the Can Reduce Web-based self-help intervention.
Part 1: Introduction
• Registration process
• Explanation of the "standard cannabis joint" concept and choice of the personal standard cannabis joint (see Figure 1), the cannabis consumption
diary, and the automated reminder emails
• Examination of the pros and cons resulting from a change in cannabis consumption patterns and further principles of motivational interviewing
to address motivation, followed by setting an appropriate target value for overall cannabis use, which is to be reached by the end of the intervention
• Explanation of the My Can Reduce folder
• Explanation of the emergency button for immediate responses to frequently asked questions and access to emergency contacts
Part 2: Key Modules (participants are encouraged to complete these modules in the order presented below; see Figure 2)
• Module 1: Strategies for goal achievement
• Module 2: Identifying risk situations
• Module 3: Dealing with cannabis craving
• Module 4: Dealing with relapses
Part 3: Further Modules (participants are encouraged to complete at least two, in any order)
• Module 5: Tobacco smoking during the reduction in cannabis use
• Module 6: Saying "no" to foster refusal skills
• Module 7: Dealing with burdens
• Module 8: Preserving achievements
Figures 1 and 2 show screenshots of the Can Reduce Web-based
intervention website. The following were also provided: a
glossary that explained the terms, definitions, and concepts used
in the intervention; a knowledge base about the history of
cannabis use; the effects and risks of cannabis use; concurrent
mental health problems; and the enhanced risks when cannabis
is mixed with tobacco and smoked, as in a previously developed
and positively evaluated cannabis group smoking cessation
program [10,24] (study arm 1 and 2). The knowledge base also
included harm reduction techniques with recommendations for
the use of cannabis [25,26].
The additional (up to two) chat counseling sessions with a
scheduled duration of 20 to 30 minutes in study arm 1 supported
behavioral change according to MI, discussed the modules of
the Web-based self-help part based on MI and CBT, and
reviewed the development of the consumption diary. Invitations
to chat sessions were sent by the counselors according to a
predefined procedure between weeks 1 and 2 for the first and
between weeks 4 and 6 for the second chat session. The chats
took place within the website in a small box at the bottom right
corner, while keeping the content of the webpage in view (see
Figure 2). It was initially planned that the structure of these chat
sessions should be fixed [1]. However, as a result of the
counselor supervision sessions, the structure of the chat session
was made more flexible and more dependent on the participants'
needs and served as a checklist for the counselors in order to
ensure that they covered all of the relevant contents.
The chat counselors received quarterly supervision sessions and
consisted of trained MI counselors, mainly psychologists or
psychiatrists with advanced or completed further education,
with at least one year of experience in treating cannabis-abusing
patients face to face. Specific quality standards were developed
for addiction chat counseling and implemented for this study
in the chat counselor supervision based on the study on the
development of a European Union framework for minimum
quality standards and benchmarks in drug demand reduction
treatment quality standards [27] and the Swiss national addiction
counseling quality standards [28].
To optimize and manage their interactions with clients,
counselors had access to a specific user management area to
add arranged chat dates, define statuses, and add personal
comments about their clients. With this tool, counselors could
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follow their clients’ progress in reducing their cannabis use
through clearly arranged charts, and look up previous chat
histories. Specific lists helped counselors track their clients (eg,
a list with all users, my clients, or my upcoming chat sessions).
The Web-based self-help intervention and the subsequent
tailored chat counseling aimed to reduce cannabis use. However,
those participants who sought cannabis abstinence were also
encouraged to make step-by-step reductions until full abstinence
was reached. In accordance with the counselor supervision
group, we deviated from the study protocol [1] by introducing
the option to dispense with a second chat session if a participant
and his/her counselor agreed that another chat would not be
needed.
Participants randomized to the waiting list had the opportunity
to participate in the Web-based self-help intervention 3 months
after registration.
Figure 1. Screenshot of the Can Reduce Web-based intervention, showing the decision on the standard cannabis joint prior to the first consumption
diary entry.
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Figure 2. Main menu of the Can Reduce Web-based intervention's study arm 1 with self-help plus chat counseling that took place within the website
in a small box at the bottom right corner.
Detailed Study Hypotheses
This study aimed at comparing the efficacy of a Web-based
self-help intervention alone or combined with chat counseling
in the reduction of the cannabis use of problematic cannabis
users within a three-arm randomized controlled trial with
assessments at baseline and 3-month follow-up (see Multimedia
Appendix 2 for the CONSORT-EHEALTH checklist [29]).
We hypothesized that Web-based interventions—which are
more interactive—would be more effective than less interactive
interventions in reducing cannabis use among problematic
cannabis users. We tested the following detailed study
hypotheses with respect to the main outcome (ie, the reduction
of the weekly cannabis used between the baseline and the
3-month follow-up):
1. Tailored chat-based counseling in combination with
Web-based self-help for the reduction of cannabis use (study
arm 1) is more effective than the waiting list control
condition (study arm 3).
2. Web-based self-help for the reduction of cannabis use (study
arm 2) is more effective than the waiting list control
condition (study arm 3).
3. Chat-based counseling in addition to Web-based self-help
for the reduction of cannabis use (study arm 1) exhibits a
trend to be more effective than Web-based self-help alone
(study arm 2).
Measurement Instruments
The primary outcome measure was the recorded quantity of
cannabis use in the previous 7 days, quantified in individually
standardized cannabis joint sizes, and as specified in the
consumption diary (see Table 2 and Schaub et al for further
details [1]). In the first step, participants chose between three
different cannabis forms presented in photographs—low-potency
cannabis plant, high-potency cannabis plant, or cannabis resin
(see Figure 1). In the second step, five different standard joints
for each category were presented (1/10 g, 1/6 g, 1/4 g, 1/3 g,
1/2 g; pictures came from the Global Drug Survey cannabis
meter [23]); these joints were either pure cannabis or cannabis
mixed with tobacco. A standard tobacco cigarette, a ruler with
centimeter and millimeter scales, the fraction amount in grams,
and an open 10 cm paper prepared to roll a joint and containing
the cannabis plant-/resin-tobacco mixture or pure cannabis were
presented. Participants chose which picture most closely
approximated the cannabis joints they most often smoke. The
chosen picture was placed in the individual consumption diary
(see Figure 1), and participants were asked to convert the
quantities of cannabis they smoked into units relative to that
picture if they exceptionally consumed cannabis in forms other
than their common standard joint. As this kind of outcome
assessment has not previously been used in an efficacy trial, we
also considered the number of cannabis use days in the last 7
days as a primary outcome [1].
The following secondary outcome instruments were applied:
1. The Cannabis Use Disorders Identification Test (CUDIT),
which is a 10-item questionnaire [30] that was constructed by
adapting the Alcohol Use Disorders Identification Test [31]. To
cover the length of the trial, this instrument was adapted to focus
on the last 3 months in its planned assessments (baseline and
3-month follow-up).
2. The Severity of Dependence Scale (SDS), which is a five-item
questionnaire that measures the severity of cannabis dependence.
Each of the five items is scored on a 4-point scale (0-3). The
total score is obtained by adding the ratings on all five items.
High scores indicate high levels of dependency [32].
3. The Cannabis Withdrawal Scale (CWS) [33], which is a
19-item questionnaire containing statements that describe
cannabis withdrawal symptoms within the last 24 hours on an
11-point scale (0-10).
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4. The Cannabis Craving Symptoms questionnaire (CCS-7),
which is a seven-item questionnaire [34] derived from the
Marijuana Craving Questionnaire [35]. Each item is rated on a
7-point scale (1-7).
5. The Fragebogen Substanzanamnese (FDA), which is a
questionnaire that ascertains the number of years of consumption
over the lifetime, the past month’s consumption, and the manner
of consumption for the Diagnostic and Statistical Manual of
Mental Disorders’ substances of abuse. This measure was
derived from the Europe Addiction Severity Index [36].
6. The short version of the Mental Health Inventory (MHI-5)
[37], which is a validated and user-friendly self-assessment
questionnaire that assesses recent mental distress and
self-reported diagnoses of depression.
None of the secondary outcome instruments has yet been
specifically validated for Internet use. Intervention satisfaction
for all modules, the diary, the chat, the knowledge base, the
instant help, and the overall satisfaction was ascertained on a
4-point scale, ranging from not at all useful to very useful.
Finally, intervention participation was assessed for completed
modules each time a participant pressed the back to the main
menu button at the very end of a module. Retention was
calculated as the percentage of days per week a user entered
any number of cannabis use in the diary.
Table 2. Study measurements and instruments.
3-month follow-up6 weeks3 weeks1 weekBaselineAssessments/instruments
xSociodemographics
xxMHI-5a
xxxxxQuantity of cannabis useb
xxxxxFrequency of cannabis useb
xxCUDITc
xxxSDSd
xxxFDAe
aMental Health Inventory (MHI-5).
b7-day point prevalence values of the quantity (in common standard joints) and frequency (the number of days on which cannabis is used) of cannabis
use were derived from the consumption diary for the preceding 7 days.
cCannabis Use Disorders Identification Test (CUDIT).
dSeverity of Dependence Scale (SDS).
eFragebogen Substanzanamnese (FDA).
Sample Size
Based on results of the study of Rooke et al [15], we expected
small to medium effect sizes of at least 0.30 (Cohen’s d) for the
reduction in the quantity of cannabis used and the frequency of
cannabis use between study arm 2 (Web-based self-help without
chat counseling) and study arm 3 (waiting list control) between
baseline and follow-up assessment, and greater effects between
study arms 1 and 3. We estimated a sample size of 89 in each
study group that would have 80% power (F test, alpha = 5%)
to detect these differences, as based on calculations with
G*Power software version 3.1. Therefore, we aimed to recruit
a total of 267 participants [1]. We had no reference values for
the expected differences in effects between study arms 1 and 2
and thus planned an exploratory study of effect sizes in case we
failed to reach significance for these study arm comparisons.
Randomization and Allocation
Once participants had completed their baseline assessment, they
were randomized by a computer program in a 1:1:1 ratio to one
of three parallel groups. As the participant information offered
full transparency on the three study arms in our nonblinded
design, we anticipated a risk that some participants might
register another account, in an effort to change their assignment
and access a different study arm. In that case, the participant
remained in the initially assigned study arm for the rest of the
day, as based on his or her IP address.
Statistical Methods
Data were analyzed according to the intention-to-treat principle.
For the ITT analyses, in departure from the study protocol, we
applied multiple imputation procedures of R (R Foundation for
Statistical Computing, Vienna, Austria) in Amelia II that have
been demonstrated to outperform other imputation methods
[38]. For each study arm, we performed 50 separate imputations
using the following as imputation variables: sex, age, education,
origin, years of cannabis use, number of finished modules, the
baseline variables for frequency and quantity of cannabis use,
alcohol use in the last 30 days (risky and normal), SDS, CUDIT,
and MHI-5. Baseline measurements were compared between
the three study arms and study participants were compared with
people entering addiction treatment according to data from the
Swiss addiction, care and therapy information (act-info)
monitoring statistics. Depending on the scale of the
corresponding outcome, Mann-Whitney U tests, chi-square
tests, or analyses of variance (ANOVA) were calculated via
SPSS version 22.0 (IBM Corporation). The calculation of the
changes between baseline and the 3-month follow-up was
modified from the protocol, as there were a considerable number
of missing values at the 6-week assessment. Regression analyses
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in R were used for the calculated differences between 3-month
follow-up and baseline, using the corresponding baseline
variables as control variables. Results from the imputed dataset
were cross-checked with the nonimputed dataset in the latter
analyses. In departure from the study protocol, we dispensed
with analyzing the Cannabis Withdrawal Scale and the Cannabis
Craving Symptoms questionnaire data [1], as very low numbers
of questionnaires were completed at intervention weeks 3 and
6. In the study dropout analysis, we conducted regression
analyses to investigate the interaction effect of relevant baseline
characteristics (ie, sociodemographic and consumption
characteristics) between those who did and those who did not
provide a 3-month follow-up. These analyses were conducted
for the total sample and for each study arm separately. Similar
analyses were conducted in the subgroup analyses.
Results
Participant Flow
Figure 3 provides an overview of the trial flow. Recruitment
started in the beginning of June 2014 and ended on February
28, 2015, after exceeding the total estimated number of 267
participants. Of the 436 Can Reduce registrants recruited, 308
(70.6%) were allocated to one of the three study arms.
Three months after the baseline assessment, participants were
invited by email to log in and complete the final study
assessment; they were reimbursed with €40 (via an online
voucher or an online charitable donation). The follow-up
assessment was performed in three steps. First, participants were
invited via email to participate in the assessment. Up to three
reminders were sent. Those participants who failed to complete
the 3-month follow-up despite these reminders were contacted
via telephone and offered an interview by study collaborators.
Those participants who refused a telephone interview were
offered an interview on the primary outcome only. Finally, 117
out of 308 participants (38.0%) could be followed up with.
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Figure 3. CONSORT-EHEALTH trial flowchart: overview of the participant flow for this trial.
Participants’ Baseline Characteristics
Table 3 provides an overview of the participants’ characteristics
and comparisons between the three study arms at baseline
assessment. In comparison with participants whose main
problem substance was cannabis in the Swiss treatment
monitoring statistics (act-info) in 2013 [7], Can Reduce
participants demonstrated a similar gender distribution (75.3%
males in Can Reduce vs 82.4% act-info, U=1.342, P=.18),
tended to be older within the age groups between 20 and 69
years old (U=2.296, P=.02), and reported a higher number of
cannabis use days in the 7 days prior to intervention start (70.9%
daily use in Can Reduce vs 41.4% act-info; 20.2% 4-6 days per
week Can Reduce vs 10.5% act-info; 5.2% 2-3 days per week
Can Reduce vs 21.7% act-info; 3.8% 1 day a week Can Reduce
vs 26.3% act-info; chi-square [df 2]=4.0, P=.046).
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Table 3. Baseline characteristics of participants.
P
χ2, ANOVAd, or
Kruskal-Wallis testTotal (n=308)
Study arm 3c
(n=93)
Study arm 2b
(n=101)
Study arm 1a
(n=114)Characteristics
.12χ
2
2=4.3 (n=308)Sex, n (%)
76 (24.7)17 (18)24 (23.8)35 (30.7)Female
232 (75.3)76 (82)77 (76.2)79 (69.3)Male
.15F2,308=1.94029.8 (10.0)31.0 (11.1)30.2 (9.2)28.4 (9.6)Age in years, mean (SD)
.14χ
2
2=3.9 (n=308)Age range, n (%)
54 (17.5)18 (19)12 (11.9)24 (21.1)≤20 years
63 (20.5)13 (14)19 (18.8)31 (27.2)21-25 years
64 (20.8)19 (20)29 (28.7)16 (14.0)26-30 years
50 (16.2)15 (16)18 (17.8)17 (14.9)31-35 years
35 (11.4)11 (12)10 (9.9)14 (12.3)36-40 years
18 (5.8)7 (8)5 (5.0)6 (5.3)41-45 years
24 (7.8)10 (11)8 (7.9)6 (5.3)46+ years
.57χ
2
10=8.6 (n=308)Highest education, n (%)
12 (3.9)5 (5)3 (3.0)4 (3.5)Not specified
41 (13.3)11 (12)12 (11.9)18 (15.8)Primary school
122 (39.6)41 (44)38 (37.6)43 (37.7)Apprenticeship
49 (15.9)17 (18)13 (12.9)19 (16.7)Secondary school
57 (18.5)13 (14)26 (25.7)18 (15.8)Technical college
27 (8.8)6 (7)9 (8.9)12 (10.5)University
.23χ
2
6=8.1 (n=308)Origin, n (%)
127 (41.2)42 (45)33 (32.7)52 (45.6)Canton of Zurich
162 (52.6)48 (52)61 (60.4)53 (46.5)Other cantons
16 (5.2)3 (3)5 (5.0)8 (7.0)Germany
3 (1.0)0 (0)2 (2.0)1 (0.9)Other countries
.69F2,308=0.3719.6 (6.1)19.1 (6.2)19.7 (6.4)19.8 (5.8)CUDITe, mean (SD)
.69F2,308=0.377.5 (3.4)7.3 (3.2)7.5 (3.6)7.7 (3.5)SDSf, mean (SD)
.90F2,308=0.1154.3 (20.5)55.1 (22.6)53.9 (20.0)54.0 (19.3)MHI-5g, mean (SD)
Number of years of substance use,
mean (SD)
.04hF2,305=3.2910.9 (8.4)12.6 (10.0)10.9 (7.6)9.6 (7.4)Cannabinoids
.97F2,228=0.032.6 (5.7)2.7 (6.4)2.6 (5.3)2.5 (5.6)Risky alcohol usei
.52F2,222=0.671.1 (3.4)0.8 (1.8)1.4 (3.8)1.1 (4.3)Cocaine
.40F2,208=0.910.8 (2.4)0.6 (2.0)1.1 (3.1)0.7 (2.0)Amphetamines
Substance use in the last 30 days, n
(%)
N/Aj
Not computable (no vari-
ance)305 (99.0)93 (100)100 (99.0)112 (98.2)Cannabinoids
.28χ
2
2=2.6 (n=226)97 (31.5)31 (33)26 (25.7)40 (35.1)Risky alcohol usei
.74χ
2
2=0.6 (n=215)20 (6.5)5 (5)8 (7.9)7 (6.1)Tranquilizers
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P
χ2, ANOVAd, or
Kruskal-Wallis testTotal (n=308)
Study arm 3c
(n=93)
Study arm 2b
(n=101)
Study arm 1a
(n=114)Characteristics
.26χ
2
2=2.7 (n=223)31 (10.1)10 (11)14 (13.9)7 (6.1)Cocaine
.90χ
2
2=0.2 (n=221)43 (14.0)14 (15)13 (12.9)16 (14.0)Amphetamines
.76χ
2
2=0.6 (n=210)14 (4.5)4 (4)4 (4.0)6 (5.3)Hallucinogens
.40χ
2
2=1.8 (n=201)1 (0.3)0 (0)1 (1.0)0 (0)Heroin
.40χ
2
2=1.9 (n=197)5 (1.6)3 (3)1 (1.0)1 (0.9)Methadone
.21χ
2
2=3.1 (n=198)6 (1.9)1 (1)1 (1.0)4 (3.5)Others
aSelf-help with chat.
bSelf-help without chat.
cWaiting list.
dAnalysis of variance (ANOVA).
eCannabis Use Disorders Identification Test (CUDIT) scores range from 0 to 40 with a cutoff of >8 for a cannabis use disorder.
fSeverity of Dependence Scale (SDS) scores range from 0 to 15 with a cutoff of ≥4 for cannabis dependence.
gMental Health Inventory (MHI-5): higher values represent improved symptoms. MHI-5 values range from 0 to 100 with a cutoff of <70 for clinically
relevant symptoms.
hP<.05, represents a significant value.
iRisky alcohol use was defined as five or more standard drinks per day on at least three days per week. A standard drink was defined as 5 cl spirits,
15-20 cl wine, or 33-45 cl beer.
jNot applicable (N/A).
Intervention Participation and Retention
Figure 4 depicts the module completion by participants in study
arms 1 and 2. Participants in the self-help with chat study arm
completed a mean of 3.2 modules and 27 out of 114 (23.7%)
of the participants received at least one chat session. Participants
in the self-help without chat study arm completed similar
numbers of self-help modules (U=-1.189, P=.23). Participants
in study arm 1 more frequently completed the consumption
diary than those in study arm 2 during their recommended 6
intervention weeks (U=-2.375, P=.02; see Figure 5). Of the 27
users in study arm 1 who received chat counseling sessions, 23
(85%) received one session and 4 (15%) received two sessions.
Figure 4. Module completion rate for study arms 1 (self-help with chat) and 2 (self-help without chat).
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Figure 5. Study retention based on the weekly completion of the consumption diary for study arms 1 (self-help with chat) and 2 (self-help without
chat) between baseline and week 6, including 3-month follow-up completion rate.
Main Outcomes
Figure 6 depicts the mean numbers of cannabis use days per
week and Figure 7 the mean weekly quantity of cannabis used
in standard joints according to the consumption diary, between
baseline and follow-up for all three study arms and based on
the nonimputed dataset.
The differences in cannabis use between baseline and the
3-month follow-up, as expressed by the mean number of
cannabis use days per week and based on the imputed data,
differed between self-help without chat versus self-help with
chat (beta= -0.75, SE = 0.32, t=-2.39, P=.02, d=0.34, 95% CI
0.07-0.61), and between self-help with chat versus waiting list
(beta= 0.70, SE = 0.32, t=2.16, P=.03, d=0.20, 95% CI -0.07
to 0.47), but not between self-help without chat versus waiting
list (beta= -0.05, SE = 0.33, t=-0.16, P=.87, d=-0.14, 95% CI
-0.43 to 0.14). In contrast, we only observed one trend to a
significant difference in the weekly quantity of standard joints
in the comparison of self-help with chat versus waiting list in
the imputed dataset (beta = 4.73, SE = 2.50, t=1.89, P=.06,
d=0.09, 95% CI -0.19 to 0.36; see Tables 4 and 5).
Figure 6. Cannabis use days per week according to the consumption diary between baseline and 3-month follow-up for all three study arms based on
the nonimputed dataset.
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Figure 7. Weekly quantity of cannabis used in number of standardized cannabis joints between baseline and 3-month follow-up for all three study arms
based on the nonimputed dataset.
Secondary Outcomes
There were no significant differences in the group comparisons
in the secondary outcomes (see Tables 4 and 5). We observed
slight improvements in mental health (MHI-5), cannabis use
disorders (CUDIT), and severity of dependence (SDS) in all
three groups (see Table 4; pre/post comparisons not reported).
Assessment of the intervention satisfaction was completed by
only a few participants at 6 months past baseline and we
therefore omit group comparisons. Not surprisingly, those who
remained in the active study arms rated their satisfaction as high
(eg, intervention satisfaction in general [19/308, 6.2%]: very
satisfied 42% [8/19], quite satisfied with most of the intervention
42% [8/19], quite unsatisfied with most of the intervention 11%
[2/19], quite unsatisfied 5% [1/19]).
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Table 4. Number of participants and mean and standard deviation changes from the imputed (50 imputations) and complete case datasets between
baseline and 3-month follow-up.
Study arm 3
(waiting list)
(n=93), mean (SD)
Study arm 2
(self-help without chat)
(n=101), mean (SD)
Study arm 1
(self-help with chat)
(n=114), mean (SD)
Outcomes
Follow-upBaselineFollow-upBaselineFollow-upBaseline
Frequency of cannabis use a
5.3 (1.8)6.3 (1.0)5.3 (1.8)6.0 (1.6)4.6 (2.1)6.0 (1.6)Imputed data
5.3 (2.5)6.7 (0.9)5.5 (2.3)6.1 (1.7)3.8 (3.0)6.1 (1.6)Complete cases
Quantity of cannabis use b
18.6 (17.7)25.8 (18.7)14.4 (11.8)23.1 (23.1)13.3 (12.0)22.3 (14.8)Imputed data
20.7 (23.7)23.6 (13.2)14.2 (13.3)25.1 (25.2)10.9 (13.8)23.0 (15.1)Complete cases
CUDIT c
16.6 (6.4)19.1 (6.2)15.6 (6.7)19.7 (6.4)16.6 (7.1)19.8 (5.8)Imputed data
16.0 (7.2)19.1 (6.2)13.0 (7.4)19.7 (6.4)12.6 (8.4)19.8 (5.8)Complete cases
SDS d
6.3 (3.3)7.3 (3.1)6.2 (3.1)7.5 (3.6)6.3 (3.3)7.7 (3.5)Imputed data
5.9 (3.8)7.3 (3.1)6.0 (3.3)7.5 (3.6)5.3 (3.8)7.7 (3.5)Complete cases
MHI-5 e
59.4 (19.4)55.1 (22.6)60.4 (19.1)53.9 (20.0)58.1 (18.2)53.9 (19.3)Imputed data
64.6 (18.3)55.1 (22.6)63.4 (20.4)53.9 (20.0)62.4 (19.8)53.9 (19.3)Complete cases
Alcohol use in the last 30 days (risky)
3.3 (4.0)4.5 (7.9)2.2 (3.0)2.4 (5.0)2.8 (2.8)3.4 (6.2)Imputed data
2.1 (4.7)4.5 (8.7)1.0 (2.6)2.5 (5.8)1.6 (2.6)3.4 (7.0)Complete cases
aBased on the weekly number of cannabis use days according to the consumption diary.
bBased on the weekly number of standard cannabis joints according to the consumption diary.
cCannabis Use Disorders Identification Test (CUDIT) scores range from 0 to 40 with a cutoff of >8 for a cannabis use disorder.
dSeverity of Dependence Scale (SDS) scores range from 0 to 15 with a cutoff of ≥4 for cannabis dependence.
eMental Health Inventory (MHI-5): higher values represent improved symptoms. MHI-5 values range from 0 to 100 with a cutoff of <70 for clinically
relevant symptoms.
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Table 5. Results for the between-study arma comparisons from the linear (and logistic) regression models and calculated effect sizes based on the
imputed dataset (50 imputations).
Cohen's d (95% CI)PtSEbetaCharacteristics
Frequency of cannabis use b
<.001-6.760.58-3.95(Intercept)
0.20 (-0.07 to 0.47).03 c2.160.320.70Arm 1 vs arm 3
-0.14 (-0.43 to 0.14).87-0.160.33-0.05Arm 2 vs arm 3
<.001-5.790.56-3.25(Intercept)
0.34 (0.07 to 0.61).02-2.390.32-0.75Arm 2 vs arm 1
Quantity of cannabis use d
<.001-6.462.24-14.50(Intercept)
0.09 (-0.19 to 0.36).061.892.504.73Arm 1 vs arm 3
0.06 (-0.22 to 0.35).121.562.423.77Arm 2 vs arm 3
<.001-5.091.92-9.78(Intercept)
0.01 (-0.26 to 0.28).69-0.392.43-0.96Arm 2 vs arm 1
CUDIT e
<.001-6.461.61-10.39(Intercept)
0.09 (-0.18 to 0.37).850.191.290.24Arm 1 vs arm 3
0.21 (-0.07 to 0.49).320.991.201.19Arm 2 vs arm 3
<.001-6.051.68-10.14(Intercept)
-0.12 (-0.39 to 0.14).410.821.160.95Arm 2 vs arm 1
SDS f
<.001-7.340.64-4.68(Intercept)
0.08 (-0.19 to 0.36).960.050.580.03Arm 1 vs arm 3
0.07 (-0.21 to 0.35).860.170.560.10Arm 2 vs arm 3
<.001-7.190.65-4.65(Intercept)
0.02 (-0.25 to 0.28).900.130.550.07Arm 2 vs arm 1
MHI-5 g
<.001-10.154.33-43.91(Intercept)
0.01 (-0.27 to 0.28).780.283.440.96Arm 1 vs arm 3
-0.09 (-0.38 to 0.19).69-0.403.42-1.38Arm 2 vs arm 3
<.001-10.374.14-42.95(Intercept)
0.11 (-0.16 to 0.38).48-0.713.28-2.34Arm 2 vs arm 1
Alcohol use in the last 30 days (risky)
<.001-5.090.56-2.84(Intercept)
-0.10 (-0.38 to 0.17).610.520.630.32Arm 1 vs arm 3
-0.16 (-0.44 to 0.12).251.140.730.83Arm 2 vs arm 3
<.001-5.460.46-2.52(Intercept)
0.06 (-0.20 to 0.33).400.840.610.51Arm 2 vs arm 1
aStudy arm 1: self-help with chat; study arm 2: self-help without chat; study arm 3: waiting list.
bBased on the weekly number of cannabis use days according to the consumption diary.
cSignificant and borderline significant differences and effect sizes are in italics.
dBased on the weekly number of standard cannabis joints according to the consumption diary.
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eCannabis Use Disorders Identification Test (CUDIT) scores range from 0 to 40 with a cutoff of >8 for a cannabis use disorder.
fSeverity of Dependence Scale (SDS) scores range from 0 to 15 with a cutoff of ≥4 for cannabis dependence.
gMental Health Inventory (MHI-5): higher values represent improved symptoms. MHI-5 scores range from 0 to 100 with a cutoff of <70 for clinically
relevant symptoms.
Dropout Analysis
Dropouts at follow-up did not differ from completers with
respect to the following baseline variables: gender (t=1.34,
P=.16), age (t=-0.24, P=.81), years of cannabis use (t=0.18,
P=.86), frequency of cannabis use in the preceding 30 days
(t=0.22, P=.83), the weekly number of standardized cannabis
joints used (t=1.20, P=.42), the SDS (t=-1.52, P=.13), the
CUDIT (t=0.49, P=.63), alcohol use in the preceding 30 days
(t=1.20, P=.23), risky alcohol use in the preceding 30 days
(t=1.56, P=.12), and the MHI-5 (t=0.40, P=.69).
Significantly more participants could be followed up who
received at least one chat session compared to those who could
not be contacted at the 3-month follow-up (17.0% vs 5.5%,
chi-square [df 2]= 7.5, P=.001).
Dropouts did not differ between the three study arms with
respect to gender (F2 =0.04, P=.96), age (F2 = 1.13, P=.27),
years of cannabis use (F2 = 0.81, P=.79), frequency of cannabis
use in the preceding 30 days (F2 = 0.91, P=.59), the standardized
cannabis use quantity (F2 = 0.93, P=.60), the SDS (F2 = 1.20,
P=.23), the CUDIT (F2 = 0.94, P=.58), alcohol use in the
preceding 30 days (F2 = 0.57, P=.97), risky alcohol use in the
preceding 30 days (F2 = 0.48, P=.98), and the MHI-5 (F2 =
1.00, P=.47) at baseline.
Nonintended Results
Although not intended as an outcome measure, we also offered
cannabis abstention in the study protocol for those participants
who wished to achieve this [1]. Self-reported 7-day point
prevalence abstinence was significantly higher in self-help with
chat (8.8%) than in the self-help without chat study arm (2.0%;
beta = -1.56, SE = 0.79, P=.05, odds ratio [OR] = 0.21, 95% CI
0.02-2.33), but not between the self-help study arm with chat
and the waiting list control group (4.3%; beta = 0.76, SE = 0.61,
P=.21, OR = 2.14, 95% CI 0.86-5.30; see Tables 6 and 7).
Table 6. Number of participants in three study arms at each time point.
Study arm 3
(waiting list)
(n=93), n (%)
Study arm 2
(self-help without chat)
(n=101), n (%)
Study arm 1
(self-help with chat)
(n=114), n (%)
Study time point
N/Aa12 (11.9)9 (7.9)Week 1
N/A9 (8.9)8 (7.0)Week 6
4 (4)2 (2.0)9 (8.8)Follow-up
aNot applicable (N/A).
Table 7. Self-reported abstinence between groups and with the corresponding logistic regression.
ORa (95% CI)PtSEbetaAbstinence at follow-up
.061.880.020.04(Intercept)
2.14 (0.86-5.30).211.250.610.76Arm 1 vs arm 3
0.45 (0.11-1.78).36-0.910.88-0.80Arm 2 vs arm 3
<.001-7.070.33-2.34(Intercept)
0.21(0.02-2.33).05 b-1.980.79-1.56Arm 2 vs arm 1
aOdds ratio (OR).
bBorderline significant difference is shown in italics.
Subgroup Analyses
Participants in study arm 1 who received at least one chat session
exhibited lower changes in their entries in the consumption
diary. This meant that they took longer to complete the
consumption diary and exhibited higher retention (change in
mean 0.3 vs 0.5; beta = -0.28, SE = 0.12, P=.03, 95% CI -0.66
to -0.53) than those who did not receive the chat session in study
arm 1. In line with this, they completed twice as many modules
(mean 5.4, SD 2.8 vs mean 2.5, SD 2.1; t=5.45, df = 96, P<.001,
95% CI 1.88-4.00). Regarding cannabis use, these two subgroups
did not differ in their reduction in frequency (change in mean
3.3 vs 1.9; beta = -1.38, SE = 0.93, P=.14, 95% CI -3.19 to 0.44)
or quantity (change in mean 15.2 vs 10.6; beta = -4.61, SE =
4.44, P=.30, 95% CI -13.32 to 4.10).
Participants in study arm 1 who did not receive a chat session
for whatever reason did reduce their frequency of cannabis use
more (change in mean 1.9) than participants in study arm 2
(change in mean 0.7) who did not have the possibility for a chat
session due to their allocation (beta = -1.97, SE = 0.60, P=.001,
95% CI -3.14 to -0.80). However, they did not differ with respect
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to the reduction in the quantity of cannabis used (change in
mean 10.6 vs 10.3; beta = -0.33, SE = 6.48, P=.96, 95% CI
-13.03 to 12.37). There were no significant differences between
these two groups with respect to module completion (mean 2.5,
SD 2.1 vs mean 2.9, SD 2.4; t=-1.18, df = 159, P=.23), but those
in study arm 2 showed lower changes in their entries in the
consumption diary (change in mean 0.4 vs 0.5; beta = -0.28, SE
= 0.12, P=.03, 95% CI -0.66 to -0.53) compared to those who
did not receive the chat session in study arm 1.
Additional Help and Adverse Events
At the 3-month follow-up, 88.0% of participants (103/117)
stated that they had not contacted any other treatment services
(7 participants in study arm 1, 2 in study arm 2, and 5 in study
arm 3). A total of 5.1% (6/117) had contacted a psychiatrist,
2.6% (3/117) a family doctor, 1.7% (2/117) a psychologist,
1.7% (2/117) a different Internet counseling service, and 1
person (0.9%) a drug counselor. During the whole study period,
5 out of 308 (1.6%) participants contacted one of the outpatient
addiction clinics from the ARUD Centers for Addiction
Medicine. None of them had to be treated as an emergency case
or had to be referred to an inpatient treatment service. Moreover,
none of the involved counselors or researchers are aware of any
adverse or serious adverse event related to the Can Reduce study
that was reported by other addiction counseling services.
Discussion
Principal Findings
The Can Reduce study could reach a different group of cannabis
users who do not enter outpatient addiction treatment services.
They are older and consume much more cannabis than outpatient
service users. The finding that we reached cannabis users with
more entrenched problems (eg, daily users) is not consistent
with the common perception that those using online
interventions have less severe problems than those entering
outpatient services. We assume that this finding was most
probably due to an age effect. Older users consume longer and
possibly also more than younger ones but might feel more
stigmatized if they enter an outpatient addiction service, due to
their greater responsibilities and roles in social relationships, at
work, and in society in general.
Can Reduce participants allocated to the self-help with chat
study arm reduced their frequency of cannabis use more than
those in the other two arms. Even cannabis abstinence was
higher among those who received additional chat counseling
relative to those who received self-help only at follow-up. There
was a trend (P=.06) for a greater reduction in quantity of
cannabis use in those who received chat versus those in the
waiting list group and only a weak tendency (P=.12) for the
comparison of those with self-help only versus waiting list.
Hence, adding one to two chat counseling sessions that are
tailored to the self-help participant data and are based on the
same therapy approaches as the self-help part can be worthwhile.
As only one-quarter received at least one chat session, the
question arose as to what was actually responsible for the
superiority of the self-help with chat study arm. The subgroup
analyses showed that those participants in study arm 1 who did
not receive a chat session reduced their frequency of cannabis
use more than those who received self-help only from the
beginning (study arm 2). Thus, even an invitation to a chat
session and the knowledge that there is a possibility to have a
chat appointment might have improved this main outcome for
cannabis use. To the best of our knowledge, there are no similar
studies in the literature that have reported a comparable effect.
However, our result is in line with the first point of the
Supportive Accountability model [39] that argues that human
support increases adherence—and potentially
outcomes—through accountability to a coach who is seen as
trustworthy, benevolent, and having expertise. We took care
that our chat counselors were perceived as possessing these
attributes in the respective chat study arm.
However, those participants who actually received at least one
chat counseling session in study arm 1 still performed better in
their reduction of cannabis use and completed more self-help
modules than their counterparts who did not receive a chat
session in the same study arm. This result is in line with a further
point of the Supportive Accountability model [39] expecting
better outcomes due to a reciprocal relationship, through which
the patient can derive explicit benefits. However, this finding
could also be related to a selection bias. Those who actually
received at least one chat appointment with their counselor could
be a selected group of more compliant and possibly more
structured participants who could profit best from their allocated
intervention.
If we compare the current results with former studies about the
reduction of cannabis use with similar therapeutic approaches,
it stands out that participants in the Can Reduce self-help without
chat study arm performed worse than those in the Australian
Reduce Your Use study [15], in which greater effects were
achieved in the reduction of the quantity (d=0.06 vs d=0.25 in
the Australian sample) and frequency of cannabis use days
(d=-0.14 vs d=0.33). This Australian study enrolled cannabis
users of a similar age range, but included more females (38.6%
vs 24.7%) and users with less severe cannabis consumption at
baseline. This may also be the reason that we did not observe
greater effects in the Severity of Dependence Scale, in contrast
to the Australian study (ITT: d=0.07 vs d=0.33). However, the
Australian study provided videos of a real person who provided
continuous MI during almost all parts of the intervention. This
clearly might have been an advantage compared to our version
with only written MI. Another possibility that could potentially
increase the engagement of self-help participants might be to
provide a personal companion with whom the participants could
identify, as we attempted in a similar ongoing trial with
problematic cocaine users [40]. The effects in the Can Reduce
self-help plus chat study arm were smaller for the quantity of
cannabis used (ITT: d=0.09 vs d=0.25) and similar for the
frequency of cannabis use days (ITT: d=0.34 vs d=0.33)
compared to the Australian self-help trial [15]. Participants in
the Can Reduce self-help with chat study arm performed better
than those in the more recent German Quit the Shit study with
respect to the reduction in the frequency of cannabis use days
(ITT: d=0.34 vs d=0.20) [11]. The German study recruited
younger participants (mean age 24.2 years, SD 5.8 vs mean age
29.8 years, SD 10.0).
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We observed a borderline significant effect in the abstention
rates between the self-help with chat and the self-help without
chat study arms. As we did not initially expect that enough
participants would maintain their abstinence, we omitted
abstinence as an outcome measure in the study protocol [1].
Abstinence rates were not reported in the German Quit the Shit
studies [12,14], but comparable differences between study arms
with respect to 3 months of abstinence were achieved in this
study (8.8%) and in the Australian study (5.8%) [15].
Setting a goal for cannabis consumption was implemented as
described in the study protocol [1]. In the introduction to the
consumption diary, we recommended that participants should
plan to reduce their cannabis use by at least 20 to 30% in the
first week and then continue with this strategy in subsequent
weeks if they succeeded. For participants who did not succeed,
we recommended that they created more modest goals until
their final aim was achieved. During the analyses of the
consumption diary patterns, we realized that there was a
considerable subgroup of participants who preferred to abstain
from cannabis even in the first week. Experiences from the chat
counseling sessions showed that, although the counselors in the
corresponding study arm strengthened this procedure in the
self-help intervention part, some participants argued that they
had learned from previous experience that they were much more
successful in stopping a potentially addictive behavior than in
reducing it. In this case, the counselors tried to encourage them
to abstain and to assist them in the maintenance of their
abstinence. However, this also resulted in some cases with a
new challenge. There was a substantial number of participants
in this subgroup who very quickly abstained from their cannabis
use and who did not log in again, although they were reminded
by automated reminder emails and/or their chat counselor, and
who then could not be reached at the follow-up assessment.
Possible strategies to prevent such early missing cases due to
abstention could be specific reminder emails sent automatically
and/or by introducing the chat counselor at an earlier stage.
Strengths and Limitations
The strengths of the Can Reduce study are that the intervention
is theory based and pretested, that this Web-based intervention
was able to reach cannabis users who otherwise would not have
sought help, and that we were able to disentangle the effects of
chat counseling additional to self-help for the reduction in
cannabis use in frequent cannabis users, three-quarters of whom
used cannabis daily. This study also possesses limitations that
merit consideration. First, we did not biologically validate
cannabis consumption for financial reasons, as we did not want
to limit participation to participants who were willing to provide,
for example, saliva samples, and as we did not want to limit
external validity. Second, we did not succeed in attaining a
better 6-week follow-up as intended in the study protocol, which
limits the explanatory power of the short-term effects of Can
Reduce. However, the 3-month follow-up rate (117/308, 38.0%)
was comparable to similar studies with problematic cannabis
users in Europe [12,14], but rather low compared to
Internet-based randomized controlled trials for the improvement
of nonaddiction-related problems. Moreover, we used the most
reliable imputation method available to handle missing data
[38] at follow-up. Third, due to ethical legislations, we had to
limit the minimal participation age to 18 years, as younger
participants would have needed parental informed consent, and
we expected that the overwhelming majority of minors would
avoid participation under these conditions. Moreover, this would
have been a contradiction with the concept of a maximally
anonymous Web-based intervention for the reduction of
cannabis use. Cannabis is still illegal in Switzerland and
Germany, from where the majority of participants in this study
come from. Fourth, participants were randomly allocated into
three study arms with slightly different sizes and a block
randomization could have prevented this.
Conclusions
In conclusion, the Can Reduce study demonstrated that
Web-based interventions possess the potential to reach heavy
cannabis users who differ from those who enter outpatient
addiction treatment services. We further conclude that offering
brief chat counseling in addition to Web-based self-help can
significantly increase success in the reduction of cannabis use
in the different groups of cannabis users investigated.
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